Cite
HARVARD Citation
Qin, S. et al. (2020). Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial. Lancet oncology. 21 (4), pp. 571-580. [Online].